Icon Wealth Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $868K | Sell |
2,497
-38
| -1% | -$13.2K | 0.1% | 129 |
|
|
2023
Q2 | $892K | Sell |
2,535
-250
| -9% | -$88K | 0.09% | 142 |
|
|
2023
Q1 | $877K | Buy |
+2,785
| New | +$877K | 0.1% | 146 |
|
|
2022
Q2 | $896K | Sell |
3,179
-654
| -17% | -$184K | 0.11% | 144 |
|
|
2022
Q1 | $1M | Sell |
3,833
-966
| -20% | -$252K | 0.1% | 150 |
|
|
2021
Q4 | $1.05M | Sell |
4,799
-141
| -3% | -$31K | 0.11% | 147 |
|
|
2021
Q3 | $896K | Buy |
4,940
+1,123
| +29% | +$204K | 0.09% | 164 |
|
|
2021
Q2 | $770K | Buy |
3,817
+137
| +4% | +$27.6K | 0.08% | 183 |
|
|
2021
Q1 | $791K | Buy |
3,680
+788
| +27% | +$169K | 0.1% | 161 |
|
|
2020
Q4 | $683K | Buy |
2,892
+552
| +24% | +$130K | 0.11% | 143 |
|
|
2020
Q3 | $637K | Sell |
2,340
-446
| -16% | -$121K | 0.12% | 125 |
|
|
2020
Q2 | $809K | Buy |
2,786
+1,272
| +84% | +$369K | 0.2% | 96 |
|
|
2020
Q1 | $360K | Sell |
1,514
-139
| -8% | -$33.1K | 0.14% | 83 |
|
|
2019
Q4 | $362K | Sell |
1,653
-202
| -11% | -$44.2K | 0.11% | 100 |
|
|
2019
Q3 | $314K | Sell |
1,855
-10
| -0.5% | -$1.69K | 0.11% | 112 |
|
|
2019
Q2 | $342K | Buy |
1,865
+322
| +21% | +$59K | 0.12% | 100 |
|
|
2019
Q1 | $284K | Sell |
1,543
-319
| -17% | -$58.7K | 0.11% | 118 |
|
|
2018
Q4 | $309K | Sell |
1,862
-12
| -0.6% | -$1.99K | 0.15% | 99 |
|
|
2018
Q3 | $361K | Sell |
1,874
-145
| -7% | -$27.9K | 0.15% | 107 |
|
|
2018
Q2 | $343K | Sell |
2,019
-964
| -32% | -$164K | 0.14% | 110 |
|
|
2018
Q1 | $486K | Sell |
2,983
-529
| -15% | -$86.2K | 0.26% | 86 |
|
|
2017
Q4 | $526K | Buy |
+3,512
| New | +$526K | 0.26% | 83 |
|